Back to the search results

FEK - Friedrich-Ebert-Krankenhaus Neumünster GmbH

FEK - Friedrich-Ebert-Krankenhaus Neumünster GmbH
FEK - Friedrich-Ebert-Krankenhaus Neumünster GmbH

Friesenstraße 11
24534 Neumünster

Phone: 04321-405-0
Fax: 04321-405-1019
Mail: ed.kef@ofni

http://www.friedrich-ebert-krankenhaus.de/
  • Number of beds: 662
  • Number of specialist departments: 18
  • Number of inpatient cases: 23.411
  • Number of partial inpatient cases: 730
  • Number of outpatient cases: 45.475
  • Hospital owners: Stadt Neumünster
  • Type of provider: öffentlich
External comparative quality assurance
Further information
  • External quality assurance according to state law
    No participation
Asthma bronchiale

Quantity performed 15
Exception? No exception
Quantity performed 60
Exception? No exception
Quantity performed 9
Exception? No exception
Overall result forecast presentation: yes
Quantity performed reporting year: 15
Quantity forecast year: 20
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 60
Quantity forecast year: 54
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 9
Quantity forecast year: 2
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 0
Quantity forecast year: 83
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
No. Explanation
CQ06 Measures for quality assurance in the care of pre-term and full-term neonates – Perinatal Centre LEVEL 2
CQ01 Quality assurance measures for inpatient care with the indication abdominal aortic aneurysm
  • Clarifying chat completed: no
  • Clarifying chat not completed: no
  • No participation in clarifying chat: no
  • Notification of non-fulfilment of nursing care not made: yes
Number Group
165 Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
90 Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
75 Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations
* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

According to Section 4 (2) of the Quality Management Guideline, facilities must provide for the prevention of and intervention in cases of violence and abuse as part of their internal quality management. The aim is to prevent, recognise and respond appropriately to abuse and violence, particularly against vulnerable patient groups such as children and adolescents or people in need of help, and also to prevent it within the facility. The respective procedure is aligned with the size of the facility, the range of services and the patients in order to define customised solutions for sensitising the teams as well as other suitable preventative and interventional measures. These may include information materials, contact addresses, training/education, codes of conduct, recommendations for action/intervention plans or comprehensive protection concepts.

Gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie haben sich Einrichtungen, die Kinder und Jugendliche versorgen, gezielt mit der Prävention von und Intervention bei (sexueller) Gewalt und Missbrauch bei Kindern und Jugendlichen zu befassen (Risiko- und Gefährdungsanalyse) und – der Größe und Organisationsform der Einrichtung entsprechend – konkrete Schritte und Maßnahmen abzuleiten (Schutzkonzept). In diesem Abschnitt geben Krankenhäuser, die Kinder und Jugendliche versorgen, an, ob sie gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie ein Schutzkonzept gegen (sexuelle) Gewalt bei Kindern und Jugendlichen aufweisen.
  • Drug commission

Medikation- Anordnung und Abgabe

04.09.2018

Anforderung und Abgabe von Arzneimitteln, Medikation - Anordnung und Abgabe, Umgang Arzneimittel, Umgang mit Betäubungsmittel, Medikationsprozess in der Pflege

18.01.2021

Medikation-Anordnung und Abgabe

04.09.2018

  • Bereitstellung einer geeigneten Infrastruktur zur Sicherstellung einer fehlerfreien Zubereitung
  • Zubereitung durch pharmazeutisches Personal
  • Anwendung von gebrauchsfertigen Arzneimitteln bzw. Zubereitungen
  • Unit-Dose System, Iris-Kontrollsystem, Vier-Augen Prinzip
  • Vorhandensein von elektronischen Systemen zur Entscheidungsunterstützung (z.B. Meona®, Rpdoc®, AIDKlinik®, ID Medics® bzw. ID Diacos® Pharma)
  • Versorgung der Patientinnen und Patienten mit patientenindividuell abgepackten Arzneimitteln durch die Krankenhausapotheke (z.B. Unit-Dose-System)
  • Laborprogramm für Apotheken für die eingene Herstellung, Zenzy System für Chemotherapie Herstellung
  • Fallbesprechungen
  • Maßnahmen zur Vermeidung von Arzneimittelverwechslung
  • Spezielle AMTS-Visiten (z. B. pharmazeutische Visiten, antibiotic stewardship, Ernährung)
  • Teilnahme an einem einrichtungsübergreifenden Fehlermeldesystem (siehe Kapitel 12.2.3.2)
  • Pharmazeutische Freigabe der täglichen Medikation, Antibiotika-Beratung
  • Aushändigung von arzneimittelbezogenen Informationen für die Weiterbehandlung und Anschlussversorgung der Patientin oder des Patienten im Rahmen eines (ggf. vorläufigen) Entlassbriefs
  • Aushändigung des Medikationsplans
  • bei Bedarf Arzneimittel-Mitgabe oder Ausstellung von Entlassrezepten
The instruments and measures to promote drug therapy safety are presented with a focus on the typical procedures of the medication process in inpatient patient care. A special feature of the medication process in the inpatient environment is the transition management during admission and discharge. The instruments and measures listed below address structural elements, e.g. special IT equipment and work materials, as well as process aspects, such as work descriptions for particularly risky process steps or concepts for securing typical risk situations . In addition, proven measures to avoid or learn from medication errors can be specified. The hospital presents here which aspects it has already dealt with and which measures it has specifically implemented. The following aspects can be presented, if necessary using free text fields:
- Admission to hospital, including anamnesis
; Instruments and measures are presented for determining the old medication (drug history), the subsequent clinical assessment and the switch to the medication available in the hospital (house list), as well as for documenting both the patient's original medication and that for hospital treatment adapted medication.
- Medication process in the hospital
In this context, the following sub-processes are assumed as examples: drug history - prescription - patient information - drug delivery - drug use - documentation - therapy monitoring - result assessment. Instruments and measures for safe medication prescription can be presented, e.g. B. in terms of readability, clarity and completeness of the documentation, but also in terms of area of ​​application, effectiveness, benefit-risk ratio, tolerability (including potential contraindications, interactions, etc.) and resource considerations. Information can also be provided to support reliable medication ordering, delivery and use or administration.
- Discharge
In particular, the measures taken by hospitals can be presented to ensure that information on drug therapy is structured and passed on to doctors and physicians providing further treatment, as well as the appropriate provision of patients with drug information, medication plans and medications. Drug prescriptions are made.
AMTS is the totality of measures to ensure an optimal medication process with the aim of reducing medication errors and thus avoidable risks for patients during drug therapy. A prerequisite for the successful implementation of these measures is that AMTS is practised as an integral part of daily routine in an interdisciplinary and multi-professional approach.
Job
Explanation

Explanation

Explanation

Explanation

ALTTO- Follow-Up (im Rahmen des HBZ) HD 21 Hodgkin Lymphom, ESCALADE bei B-Cell Lymphoma, CZAR-I, PREPARE 2.0 bei Nierenzellkarzinom, CIRCULATE bei Darmkrebs Stage II, NIS: Lungen carcinom CLL, CML, Nieren Ca.

Explanation

Explanation

In Zusammenarbeit mit dem Universitätsklinikum Hamburg Eppendorf UKE und dem Universitätsklinikum Schleswig-Holstein - Campus Kiel.

Explanation

Hochschulstandort Neumünster

Explanation

PanaMa Studie für Metastatic colorectal cancer, FOOTPATH Studie für metastatic pancreatic cancer., Alternative C Phase II, GOAL II

Explanation

Training in other healing professions
Comment

25 Ausbildungsplätze

Comment

Absolvierung des obligatorischen Praktikums im FEK.

Comment

Absolvierung des obligatorischen Praktikums im FEK

Comment

Absolvierung des obligatorischen Praktikums im FEK

Comment

Absolvierung des obligatorischen Praktikums im FEK

Comment

Absolvierung des obligatorischen Praktikums im FEK

Comment

Absolvierung des obligatorischen Praktikums im FEK

Comment

Absolvierung des obligatorischen Praktikums im FEK

Comment

Absolvierung des obligatorischen Praktikums im FEK

Comment

Comment

Im 2021 waren 37 Ausbildungsplätze im Kurs 19/22 belegt, der in 2022 abschlossen hat. Einen Neustart für diese Ausbildung wird es nicht mehr geben.

Comment

Comment

65 Ausbildungsplätze

Günter Humpe-Waßmuth

Patientenombudsmann

Friesenstraße 11
24534 Neumünster

Phone: 04321 -405-2223
Mail: ed.kef@aw-epmuh

Tanja Goos

Beschwerdemanagerin

Friesenstraße 11
24534 Neumünster

Phone: 04321 -405-2222
Mail: ed.kef@soog.ajnat

Tanja Goos

Beschwerdemanagerin

Friesenstraße 11
24534 Neumünster

Phone: 04321 -405-2222
Mail: ed.kef@soog.ajnat

Andrea Vollert

Leitung Stabsstelle Qualitäts- und Risikomanagement

Friesenstraße 11
24534 Neumünster

Phone: 04321 -405-1004
Mail: ed.kef@trellov.aerdna

PD Dr. med. Andrea Pace

Ärztlicher Direktor, Chefarzt Gastroenterologie

Friesenstraße 11
24534 Neumünster

Phone: 04321 -405-7041
Mail: ed.kef@ecap.aerdna

Malte Dobin

Leitung Apotheke / Ansprechpartner Arzneimitteltherapiesicherheit

Friesenstraße 11
24534 Neumünster

Phone: 04321 -405-3600
Mail: ed.kef@nibod.etlam

Volker Wegner

Beauftragte für Barrierefreiheit

Friesenstraße 11
24534 Neumünster

Phone: 04321 -405-1640
Mail: ed.kef@rengew.reklov

Friesenstraße 11
24534 Neumünster

Phone: 04321-405-0
Fax: 04321-405-1019
Mail: ed.kef@ofni

Christian de la Chaux

Pflegedirektor

Friesenstraße 11
24534 Neumünster

Phone: 04231 -405-3001
Mail: ed.kef@xuahcaled.naitsirhc

Roman Fischer

Klinikmanager

Friesenstraße 11
24534 Neumünster

Phone: 04321 -405-1012
Mail: ed.kef@rehcsif.namor

Kerstin Ganskopf

Geschäftsführerin

Friesenstraße 11
24534 Neumünster

Phone: 04321 -405-1011
Mail: ed.kef@fpoksnag.nitsrek

Kerstin Ganskopf

Geschäftsführerin

Friesenstraße 11
24534 Neumünster

Phone: 04321 -405-1011
Mail: ed.kef@fpoksnag.nitsrek

PD Dr. med. Andrea Pace

Ärztlicher Direktor

Friesenstraße 11
24534 Neumünster

Phone: 04321 -405-7041
Mail: ed.kef@ecap.aerdna

No

IK: 260101488

Location number: 772073000

Old location number: 772073000

Hospital portrait for download